Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy
BM Ghadimi, M Grade, MJ Difilippantonio…�- Journal of clinical�…, 2005 - ascopubs.org
Purpose There is a wide spectrum of tumor responsiveness of rectal adenocarcinomas to
preoperative chemoradiotherapy ranging from complete response to complete resistance�…
preoperative chemoradiotherapy ranging from complete response to complete resistance�…
[HTML][HTML] STAT3: a novel molecular mediator of resistance to chemoradiotherapy
M Spitzner, R Ebner, HA Wolff, BM Ghadimi…�- Cancers, 2014 - mdpi.com
Chemoradiotherapy (CRT) represents a standard treatment for many human cancers,
frequently combined with radical surgical resection. However, a considerable percentage of�…
frequently combined with radical surgical resection. However, a considerable percentage of�…
[HTML][HTML] The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials
J Gaedcke, B Gunawan, M Grade, R Sz�ke…�- …�archives of surgery, 2010 - Springer
Purpose The prognosis of patients with pancreatic cancer remains poor, even after
potentially curative R0 resection. This discrepancy may be due to the histopathological�…
potentially curative R0 resection. This discrepancy may be due to the histopathological�…
The consequences of chromosomal aneuploidy on the transcriptome of cancer cells
T Ried, Y Hu, MJ Difilippantonio, BM Ghadimi…�- …�et Biophysica Acta (BBA�…, 2012 - Elsevier
Chromosomal aneuploidies are a defining feature of carcinomas, ie, tumors of epithelial
origin. Such aneuploidies result in tumor specific genomic copy number alterations. The�…
origin. Such aneuploidies result in tumor specific genomic copy number alterations. The�…
Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping
M Macville, E Schröck, H Padilla-Nash, C Keck…�- Cancer research, 1999 - AACR
We revisited the cytogenetic alterations of the cervical adenocarcinoma cell line HeLa
through the use of spectral karyotyping (SKY), comparative genomic hybridization (CGH)�…
through the use of spectral karyotyping (SKY), comparative genomic hybridization (CGH)�…
Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant
T Fehm, A Sagalowsky, E Clifford, P Beitsch…�- Clinical cancer�…, 2002 - AACR
Purpose: Numerous studies of circulating epithelial cells (CECs) have been described in
cancer patients, and genetic abnormalities have been well documented. However, with one�…
cancer patients, and genetic abnormalities have been well documented. However, with one�…
Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal�…
BM Ghadimi, DL Sackett…�- Genes�…, 2000 - Wiley Online Library
Measurement of the nuclear DNA content allows classification of human cancers as either
diploid or aneuploid. To gain further insight into mechanisms of aneuploidy, we compared�…
diploid or aneuploid. To gain further insight into mechanisms of aneuploidy, we compared�…
Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas
BM Ghadimi, E Schr�ck, RL Walker, D Wangsa…�- The American journal of�…, 1999 - Elsevier
To screen pancreatic carcinomas for chromosomal aberrations we have applied molecular
cytogenetic techniques, including fluorescent in situ hybridization, comparative genomic�…
cytogenetic techniques, including fluorescent in situ hybridization, comparative genomic�…
Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer
G Zhang, P He, H Tan, A Budhu, J Gaedcke…�- Clinical cancer�…, 2013 - AACR
Purpose: To identify metabolic pathways that are perturbed in pancreatic ductal
adenocarcinoma (PDAC), we investigated gene-metabolite networks with integration of�…
adenocarcinoma (PDAC), we investigated gene-metabolite networks with integration of�…
A novel MIF signaling pathway drives the malignant character of pancreatic cancer by targeting NR3C2
Pancreatic cancers with aberrant expression of macrophage migration inhibitory factor (MIF)
are particularly aggressive. To identify key signaling pathways that drive disease�…
are particularly aggressive. To identify key signaling pathways that drive disease�…